• Incon designates call-option holders for KRW 7.5 billion of its KRW 15 billion privately placed unsecured convertible bonds.
• Largest shareholder Mirae I&G receives rights over KRW 4.5 billion; affiliate K Bio Labs receives rights over KRW 3 billion.
• The designations cover 50% of the bonds, issued November 6, 2026, maturing November 6, 2029.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incon Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261109000239), on November 09, 2026, and is solely responsible for the information contained therein.